Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: Expression profile and fetus protective role at different stages of gestation

Biology of Reproduction

Volumn 88, Issue 3, 2013, Pages

  Ahmadimoghaddam, Davoud ^a   Zemankova, Lenka ^a   Nachtigal, Petr ^a   Dolezelova, Eva ^a   Neumanova, Zuzana ^a   Cerveny, Lukas ^a   Ceckova, Martina ^a   Kacerovský, Marian ^b   Micuda, Stanislav ^c   Staud, Frantisek ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Fetal exposure; Multidrug and toxin extrusion protein 1; Organic cation transporter 3; Placental transport; Pregnancy

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; MESSENGER RNA; MULTIDRUG AND TOXIN EXTRUSION 1; MULTIDRUG AND TOXIN EXTRUSION 2; OCTAMER TRANSCRIPTION FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CYTOPLASM; DETOXIFICATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GIANT CELL; HUMAN; HUMAN TISSUE; KIDNEY; MATERNAL AGE; MATERNAL BLOOD; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STABLE EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

ANIMALS; ANTIPORTERS; BLOTTING, WESTERN; FEMALE; FETAL DEVELOPMENT; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; ORGANIC CATION TRANSPORT PROTEINS; PLACENTA; PREGNANCY; RATS; RATS, WISTAR; RNA, MESSENGER;

RATTUS;

EID: 84876737773     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.105064     Document Type: Article

References (39)

1. Staud F, Cerveny L, Ceckova M. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target 2012; 20(9):736-763.
2. Vähäkangas KH, Veid J, Karttunen V, Partanen H, Sieppi E, Kummu M, Myllynen P, Loikkanen J. The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics. In: Gupta RC (ed.), Reproductive and Developmental Toxicology. London: Academic Press; 2011:1051-1065.
3. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007; 24:1227-1251.
4. Klaassen CD, Aleksunes LM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010; 62:1-96.
5. Yonezawa A, Inui K. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics. Br J Pharmacol 2011; 164:1817-1825.
6. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9:215-236.
7. Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A 2005; 102:17923-17928.
8. Ahmadimoghaddam D, Hofman J, Zemankova L, Nachtigal P, Dolezelova E, Cerveny L, Ceckova M, Micuda S, Staud F. Synchronized activity of organic cation transporter 3 (Oct3/Slc22a3) and multidrug and toxin extrusion 1 (Mate1/Slc47a1) transporter in transplacental passage of MPP+ in rat. Toxicol Sci 2012; 128:471-481.
9. Verhaagh S, Schweifer N, Barlow DP, Zwart R. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. Genomics 1999; 55:209-218.
10. Shuster DL, Bammler TK, Beyer RP, Macdonald JW, Tsai JM, Farin FM, Hebert MF, Thummel KE, Mao Q. Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice. Drug Metab Dispos 2013; 41:332-342.
11. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
12. Meller M, Vadachkoria S, Luthy DA, Williams MA. Evaluation of housekeeping genes in placental comparative expression studies. Placenta 2005; 26:601-607.
13. Seidel SD, Hung SC, Lynn Kan H, Bhaskar Gollapudi B. Background gene expression in rat kidney: influence of strain, gender, and diet. Toxicol Sci 2006; 94:226-233.
14. Radilova H, Libra A, Holasova S, Safarova M, Viskova A, Kunc F, Buncek M. COX-1 is coupled with mPGES-1 and ABCC4 in human cervix cancer cells. Mol Cell Biochem 2009; 330:131-140.
15. Murthi P, Fitzpatrick E, Borg AJ, Donath S, Brennecke SP, Kalionis B. GAPDH, 18S rRNA and YWHAZ are suitable endogenous reference genes for relative gene expression studies in placental tissues from human idiopathic fetal growth restriction. Placenta 2008; 29:798-801.
16. Patel P, Boyd CA, Johnston DG, Williamson C. Analysis of GAPDH as a standard for gene expression quantification in human placenta. Placenta 2002; 23:697-698.
17. Patel P, Weerasekera N, Hitchins M, Boyd CA, Johnston DG, Williamson C. Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATPA, OATP-C,OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta. Placenta 2003; 24:39-44.
18. Chen WS, Chang HY, Chang JT, Liu JM, Li CP, Chen LL, Chang HL, Chen CC, Huang TS. Novel rapid tissue lysis method to evaluate cancer proteins: correlation between elevated Bcl-X(L) expression and colorectal cancer cell proliferation. World J Gastroenterol 2005; 11:5162-5168.
19. Brcakova E, Fuksa L, Cermanova J, Kolouchova G, Hroch M, Hirsova P, Martinkova J, Staud F, Micuda S. Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats. Biol Pharm Bull 2009; 32:1978-1985.
20. Cygalova L, Ceckova M, Pavek P, Staud F. Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in rat. Toxicol Lett 2008; 178:176-180.
21. Ludbrook J. Advantages of permutation (randomization) tests in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 1994; 21:673-686.
22. Ludbrook J, Dudley H. Why permutation tests are superior to t and F tests in biomedical research. Am Stat 1998; 52:127-132.
23. Ciarimboli G. Organic cation transporters. Xenobiotica 2008; 38:936-971.
24. Alnouti Y, Petrick JS, Klaassen CD. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 2006; 34:477-482.
25. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 1998; 273:15971-15979.
26. Sata R, Ohtani H, Tsujimoto M, Murakami H, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Nagata H, Tsukimori K, Nakano H, Sawada Y. Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther 2005; 315:888-895.
27. Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH, Ganapathy V. Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol 2000; 279:F449-F458.
28. Ceckova-Novotna M, Pavek P, Staud F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 2006; 22:400-410.
29. Hahnova-Cygalova L, Ceckova M, Staud F. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy. Drug Metab Rev 2011; 43:53-68.
30. Terada T, Masuda S, Asaka J, Tsuda M, Katsura T, Inui K. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1. Pharm Res 2006; 23:1696-1701.
31. Aleksunes LM, Cui Y, Klaassen CD. Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos 2008; 36:1960-1970.
32. Lickteig AJ, Cheng X, Augustine LM, Klaassen CD, Cherrington NJ. Tissue distribution, ontogeny and induction of the transporters multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice. Life Sci 2008; 83:59-64.
33. Sai Y, Nishimura T, Ochi K, Tanaka N, Takagi A, Tomi M, Kose N, Kobayashi Y, Miyakoshi N, Kitagaki S, Mukai C, Nakashima E. Protoncoupled erythromycin antiport at rat blood-placenta barrier. Drug Metab Dispos 2010; 38:1576-1581.
34. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012; 13:227-232.
35. Terada T, Inui K. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem Pharmacol 2008; 75:1689-1696.
36. Sayre LM. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Lett 1989; 48:121-149.
37. Weissman EM, Norman AB, Calderon SF, Zubrycki EM, el-Etri MM, Shipley MT, Sanberg PR. The effect of prenatal treatment with MPTP or MPP+ on the development of dopamine-mediated behaviors in rats. Pharmacol Biochem Behav 1989; 34:545-551.
38. Sai T, Uchida K, Nakayama H. Acute toxicity of MPTP and MPP(+) in the brain of embryo and newborn mice. Exp Toxicol Pathol 2013; 65(1-2):113-119.
39. Muthian G, Mackey V, King J, Charlton CG. Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Neuroscience 2010; 169:1085-1093.